Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ramona Strob"'
Autor:
Adrian Dobrowolski, Peter Walzel, Markus Thommes, Ramona Strob, Damian Pieloth, Helmut Wiggers, Gerhard Schaldach
Publikováno v:
Advanced Powder Technology. 29:2920-2927
The versatile use of submicron-sized particles (0.1–1 μm) requires new manufacturing methods. One possibility for the preparation of submicron-sized particles is spray drying. However, the generation of small droplets at a high production rate and
Autor:
Jan Felix Dräger-Gillessen, Ramona Strob, Markus Thommes, Damian Pieloth, Helmut Wiggers, Gerhard Schaldach, Adrian Dobrowolski
Publikováno v:
International journal of pharmaceutics. 567
Manufacturing poorly water-soluble active pharmaceutical ingredients (API) with sufficient bioavailability is a significant challenge in pharmaceutical research. A higher bioavailability can reduce both the applied dosage and the side effects for the
Autor:
Ramona Strob, Matthias Rodeck, Peter Walzel, Tejas Babaria, Gerhard Schaldach, Markus Thommes
Publikováno v:
Journal of Aerosol Science. 140:105483
The generation of a secondary aerosol after impact, consisting of smaller droplets at a given velocity and mass flow, is relevant for various applications. Thus far, the investigations and modelling approaches on spray impact are based on extrapolati
Preparation of spray dried submicron particles: Part A - Particle generation by aerosol conditioning
Publikováno v:
International journal of pharmaceutics. 548(1)
The preparation of submicron-sized particles is relevant in chemical, food and pharmaceutical applications. In pharmaceutics, spray dried submicron-sized particles (0.1–1 µm) can increase the dissolution rate as well as the solubility of poorly wa
Autor:
Adrian Dobrowolski, Markus Thommes, Ramona Strob, Helmut Wiggers, Damian Pieloth, Jessica Nietfeld
Publikováno v:
International journal of pharmaceutics. 548(1)
The low bioavailability of poorly water-soluble drugs is currently one of the major focuses of pharmaceutical research. One strategy currently being investigated to overcome this limitation is to decrease the particle size of the active pharmaceutica